• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Blood viscosity disorders as an etiopathological factor in sudden deafness].

作者信息

García Callejo F J, Velert Vila M M, Orts Alborch M H, Pardo Mateu L, Monzó Gandía R, Marco Algarra J

机构信息

Servicio de ORL, Hospital Clínico Universitario, Valencia.

出版信息

Acta Otorrinolaringol Esp. 1997 Oct;48(7):517-22.

PMID:9489151
Abstract

Because idiopathic sudden deafness is regarded as the result of a cochlear microcirculation disorder, its treatment has been based mainly on vasoactive therapy with little regard for the blood-flow conditions produced by these circumstances. In a group of 16 patients with sudden-onset deafness, we determined blood viscosity at different shear rates, as well as erythrocyte aggregability, deformability, and filterability, and other potentially influential parameters, such as hematobrit, fibrinogen, and leukocyte and platelet count. These values correlated with hearing loss and average recovery after conventional treatment. Our results showed a trend to high blood viscosity in patients in relation to a control group of persons with normal hearing, with a notorious increase in aggregability, which correlated significantly with recovery of hearing capacity, and a decrease in blood filterability, which correlated with average hearing loss. This suggests a potential etiopathogenic mechanism of the disease and an alternative treatment complementary to current treatment.

摘要

相似文献

1
[Blood viscosity disorders as an etiopathological factor in sudden deafness].
Acta Otorrinolaringol Esp. 1997 Oct;48(7):517-22.
2
[Pathophysiological rationale for the use of piracetam in sudden deafness].
Acta Otorrinolaringol Esp. 2000 May;51(4):319-26.
3
[Hypercholesteremia and hyperfibrinogenemia in sudden deafness].[突发性耳聋中的高胆固醇血症与高纤维蛋白原血症]
Laryngorhinootologie. 1997 Aug;76(8):453-7. doi: 10.1055/s-2007-997460.
4
[Sudden hearing loss in 1997: etiopathogenic hypothesis, management, prognostic factors and treatment].[1997年突发性听力损失:病因假说、管理、预后因素及治疗]
Ann Otolaryngol Chir Cervicofac. 1997;114(7-8):251-66.
5
[Fibrinolytic therapy in sudden deafness with recombinant tissue-type plasminogen activator. Hemorheologic and therapeutic effects].
Laryngorhinootologie. 1991 Jul;70(7):353-8. doi: 10.1055/s-2007-998052.
6
Whole-blood filterability in sudden deafness.
Laryngoscope. 1991 Jan;101(1 Pt 1):65-7. doi: 10.1288/00005537-199101000-00011.
7
[Rheologic problems of microcirculation and consequences of drug therapy for sudden deafness].[微循环的流变学问题及突发性耳聋的药物治疗后果]
Laryngol Rhinol Otol (Stuttg). 1983 Feb;62(2):62-4.
8
Apheresis for idiopathic sudden hearing loss: reviewing the evidence.用于特发性突发性感音神经性听力损失的血液成分单采术:证据综述
J Clin Apher. 2006 Dec;21(4):241-5. doi: 10.1002/jca.20081.
9
[Treatment protocol for sudden deafness].[突发性耳聋的治疗方案]
Acta Otorrinolaringol Esp. 1997 Oct;48(7):513-6.
10
[Hemorheological disorders in patients with sudden deafness].[突发性耳聋患者的血液流变学紊乱]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 1997 Mar;14(1):11-4, 57.

引用本文的文献

1
Blood Viscosity in COVID-19 Patients With Sudden Deafness.COVID-19 患者突发性聋的血液黏度。
Acta Otorrinolaringol Esp (Engl Ed). 2022 Mar-Apr;73(2):104-112. doi: 10.1016/j.otoeng.2022.02.004. Epub 2022 Feb 23.
2
[Blood viscosity in COVID-19 patients with sudden deafness].[新型冠状病毒肺炎合并突发性耳聋患者的血液黏度]
Acta Otorrinolaringol Esp. 2022 Mar-Apr;73(2):104-112. doi: 10.1016/j.otorri.2021.07.001. Epub 2021 Jul 15.
3
[Sudden hearing loss: a retrospective study about 36 cases].[突发性听力损失:36例回顾性研究]
Pan Afr Med J. 2014 Dec 22;19:399. doi: 10.11604/pamj.2014.19.399.3677. eCollection 2014.